TY - JOUR
T1 - Multiple myeloma, version 2.2016
T2 - Clinical practice guidelines in oncology
AU - Anderson, Kenneth C.
AU - Alsina, Melissa
AU - Atanackovic, Djordje
AU - Biermann, J. Sybil
AU - Chandler, Jason C.
AU - Costello, Caitlin
AU - Djulbegovic, Benjamin
AU - Fung, Henry C.
AU - Gasparetto, Cristina
AU - Godby, Kelly
AU - Hofmeister, Craig
AU - Holmberg, Leona
AU - Holstein, Sarah
AU - Huff, Carol Ann
AU - Kassim, Adetola
AU - Krishnan, Amrita Y.
AU - Kumar, Shaji K.
AU - Liedtke, Michaela
AU - Lunning, Matthew
AU - Raje, Noopur
AU - Singhal, Seema
AU - Smith, Clayton
AU - Somlo, George
AU - Stockerl-Goldstein, Keith
AU - Treon, Steven P.
AU - Weber, Donna
AU - Yahalom, Joachim
AU - Shead, Dorothy A.
AU - Kumar, Rashmi
N1 - Publisher Copyright:
© JNCCN-Journal of the National Comprehensive Cancer Network.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. Recent statistics from the American Cancer Society indicate that the incidence of MM is increasing. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) included in this issue address management of patients with solitary plasmacytoma and newly diagnosed MM.
AB - Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. Recent statistics from the American Cancer Society indicate that the incidence of MM is increasing. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) included in this issue address management of patients with solitary plasmacytoma and newly diagnosed MM.
UR - http://www.scopus.com/inward/record.url?scp=84947223887&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2015.0167
DO - 10.6004/jnccn.2015.0167
M3 - Review article
C2 - 26553768
AN - SCOPUS:84947223887
SN - 1540-1405
VL - 13
SP - 1398
EP - 1435
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 11
ER -